CHARLOTTE, N.C., February 19, 2014 -- NYU Langone Medical Center and SonaCare Medical, LLC (SonaCare Medical), a global leader in minimally invasive focused therapeutic ultrasound technologies, announced a collaboration to develop tools and clinical procedures based on the use of advanced focused therapeutic ultrasound technology. Together, NYU Langone Medical Center and SonaCare Medical anticipate providing physician education, training and technology development across multiple disciplines.
Press Releases from SonaCare Medical
Strong global demand for the Sonablate® HIFU device results in six device sales in 2013
Charlotte, N.C., February 7, 2014 -- SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, sold six Sonablate® HIFU devices for the non-invasive treatment of prostate cancer in 2013.
Novel SonaSurgery Treatment, Using "Sound Based Therapy," Will Be Introduced
Charlotte, N.C., January 7, 2014 -- SonaCare Medical, LLC (SonaCare Medical), a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, will present at the upcoming J.P. Morgan Healthcare Conference being held in San Francisco, CA. Michael Klein, Chief Executive Officer of SonaCare Medical, will present on Tuesday, January 14, 2014 at 4:30 p.m. PST.
Read more: SonaCare Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Vincent Prajka Brings Significant Financial, Operational and Administrative Expertise as the Company Nears U.S. Commercialization of its High Intensity Focused Ultrasound (HIFU) Treatment Platform
Charlotte, N.C. - September 4, 2013 -- SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced today that Vincent (Vinny) Prajka has joined as Chief Financial Officer.
Read more: SonaCare Medical Expands Management Team with Chief Financial Officer
Results demonstrate that MRI-US registration and fusion software can inform the planning of new tissue preserving treatments for prostate cancer using the Sonablate® 500 system
CHARLOTTE, N.C. and LONDON, Thursday, July 25, 2013 – Study results published in the current issue of British Journal of Urology International (10.1111/bju.12223) demonstrate that new software to register and fuse information from magnetic resonance imaging (MRI) and ultrasound (US) images enables intraoperative visualization of tumors, not ordinarily seen in a US image. This technology has the potential to support new tissue-preserving treatments for prostate cancer, such as focal therapy.
With Successful Launch of Sonatherm® HIFU Surgical Ablation System at AUA, SonaCare Medical Delivers on the Promise of Image Guided Minimally Invasive Technology
SAN DIEGO, Thursday, May 23, 2013 - The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108th Annual Meeting of the American Urological Association (AUA), in San Diego. According to SonaCare Medical, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, the need for image-guided technologies to better identify and localize disease, and for urologists to consider minimally invasive ablative treatments, was addressed in the Opening Session, the Dr. W. Whitmore Memorial Lecture, and multiple sessions throughout the AUA meeting.
- SonaCare Medical Partners with University College London to Create Center of Excellence for HIFU Surgical Ablation Technology
- SonaCare Medical to Launch FDA-Cleared Sonatherm® HIFU Surgical Ablation System at American Urology Association (AUA) Annual Meeting
- SonaCare Medical to Integrate SmartTarget Image Registration and Fusion Software from University College London into Industry Leading Prostate HIFU System
- SonaCare Medical Successfully Launches New Products at European Association of Urology (EAU)
